| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |